ArticleScientific reports2026

Pre-treatment of cabozantinib prior to hypofractionated radiotherapy increases immunomodulatory effects and tumor size reduction in a 4T1 breast cancer murine model.

Fatemeh Keshavarz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.